Clinical Trial

Dexamethasone for Prevention of Postoperative Vomiting After Laparoscopic Gynecologic Surgery

Study acronym: PONV-DEX-GYN
Completed
View on ClinicalTrials.gov →
Summary
Postoperative nausea and vomiting (PONV) are common and distressing complications following laparoscopic gynecologic surgery. This randomized controlled trial evaluated whether a single preoperative intravenous dose of dexamethasone reduces postoperative vomiting compared with placebo and explored patient-related risk factors associated with PONV. Women undergoing elective laparoscopic gynecologic surgery were randomly assigned to receive dexamethasone (5 mg IV) or placebo at induction of anesthesia. The primary outcome was the incidence of postoperative vomiting within 24 hours, with secondary outcomes including nausea severity, rescue antiemetic use, and postoperative recovery parameters.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-12.
Trial Details
NCT Number NCT07421817
Lead Sponsor Rawalpindi Medical College
Conditions Postoperative Nausea and Vomiting (PONV)
Enrollment 120 participants
Start Date 2017-10-01
Primary Completion 2018-03-31 (estimated)
Study Completion 2018-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-20